- Home
- WLK vs PEN Comparison
WLK vs PEN Comparison
Compare WLK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLK
- PEN
- Stock Information
- Founded
- WLK 1986
- PEN 2004
- Country
- WLK United States
- PEN United States
- Employees
- WLK N/A
- PEN N/A
- Industry
- WLK Major Chemicals
- PEN Medical/Dental Instruments
- Sector
- WLK Industrials
- PEN Health Care
- Exchange
- WLK Nasdaq
- PEN Nasdaq
- Market Cap
- WLK 10.1B
- PEN 9.7B
- IPO Year
- WLK 2004
- PEN 2015
- Fundamental
- Price
- WLK $76.18
- PEN $235.50
- Analyst Decision
- WLK Buy
- PEN Strong Buy
- Analyst Count
- WLK 15
- PEN 16
- Target Price
- WLK $96.33
- PEN $307.50
- AVG Volume (30 Days)
- WLK 1.0M
- PEN 345.6K
- Earning Date
- WLK 10-30-2025
- PEN 11-05-2025
- Dividend Yield
- WLK 2.77%
- PEN N/A
- EPS Growth
- WLK N/A
- PEN 916.05
- EPS
- WLK N/A
- PEN 3.74
- Revenue
- WLK $11,759,000,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- WLK N/A
- PEN $15.52
- Revenue Next Year
- WLK $4.55
- PEN $14.20
- P/E Ratio
- WLK N/A
- PEN $62.99
- Revenue Growth
- WLK N/A
- PEN 12.92
- 52 Week Low
- WLK $68.55
- PEN $205.80
- 52 Week High
- WLK $139.59
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- WLK 43.52
- PEN 32.76
- Support Level
- WLK $74.58
- PEN $248.22
- Resistance Level
- WLK $80.28
- PEN $260.00
- Average True Range (ATR)
- WLK 2.35
- PEN 7.77
- MACD
- WLK 0.18
- PEN -1.16
- Stochastic Oscillator
- WLK 25.51
- PEN 9.06
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.